Literature DB >> 24032557

Functionally biased signalling properties of 7TM receptors - opportunities for drug development for the ghrelin receptor.

B Sivertsen1, N Holliday, A N Madsen, B Holst.   

Abstract

UNLABELLED: The ghrelin receptor is a 7 transmembrane (7TM) receptor involved in a variety of physiological functions including growth hormone secretion, increased food intake and fat accumulation as well as modulation of reward and cognitive functions. Because of its important role in metabolism and energy expenditure, the ghrelin receptor has become an important therapeutic target for drug design and the development of anti-obesity compounds. However, none of the compounds developed so far have been approved for commercial use. Interestingly, the ghrelin receptor is able to signal through several different signalling pathways including Gαq , Gαi/o , Gα12/13 and arrestin recruitment. These multiple signalling pathways allow for functionally biased signalling, where one signalling pathway may be favoured over another either by selective ligands or through mutations in the receptor. In the present review, we have described how ligands and mutations in the 7TM receptor may bias the receptors to favour either one G-protein over another or to promote G-protein independent signalling pathways rather than G-protein-dependent pathways. For the ghrelin receptor, both agonist and inverse agonists have been demonstrated to signal more strongly through the Gαq -coupled pathway than the Gα12/13 -coupled pathway. Similarly a ligand that promotes Gαq coupling over Gαi coupling has been described and it has been suggested that several different active conformations of the receptor may exist dependent on the properties of the agonist. Importantly, ligands with such biased signalling properties may allow the development of drugs that selectively modulate only the therapeutically relevant physiological functions, thereby decreasing the risk of side effects. LINKED ARTICLES: This article is part of a themed section on Neuropeptides. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2013.170.issue-7.
© 2013 The British Pharmacological Society.

Entities:  

Keywords:  7TM receptor; GPCR; biased agonism; biased signalling; ghrelin receptor

Mesh:

Substances:

Year:  2013        PMID: 24032557      PMCID: PMC3838681          DOI: 10.1111/bph.12361

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  129 in total

1.  The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling.

Authors:  Zsuzsanna Gáborik; Gowraganahalli Jagadeesh; Meng Zhang; András Spät; Kevin J Catt; László Hunyady
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

2.  Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.

Authors:  Birgitte Holst; Manja Lang; Erik Brandt; Anders Bach; Andrew Howard; Thomas M Frimurer; Annette Beck-Sickinger; Thue W Schwartz
Journal:  Mol Pharmacol       Date:  2006-06-23       Impact factor: 4.436

3.  Modulation of constitutive activity and signaling bias of the ghrelin receptor by conformational constraint in the second extracellular loop.

Authors:  Jacek Mokrosiński; Thomas M Frimurer; Bjørn Sivertsen; Thue W Schwartz; Birgitte Holst
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

4.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

5.  Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits.

Authors:  P Crespo; N Xu; W F Simonds; J S Gutkind
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

Review 6.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1995-07       Impact factor: 14.819

7.  Growth hormone secretagogue binding sites in peripheral human tissues.

Authors:  M Papotti; C Ghè; P Cassoni; F Catapano; R Deghenghi; E Ghigo; G Muccioli
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

8.  Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor.

Authors:  Nicholas D Holliday; Birgitte Holst; Elena A Rodionova; Thue W Schwartz; Helen M Cox
Journal:  Mol Endocrinol       Date:  2007-08-23

9.  Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-agonists but not allosteric regulators for activation of the G protein Galpha(o1) by the Ghrelin receptor.

Authors:  Kirstie A Bennett; Christopher J Langmead; Alan Wise; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2009-07-22       Impact factor: 4.436

10.  Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.

Authors:  Guillaume Lebon; Tony Warne; Patricia C Edwards; Kirstie Bennett; Christopher J Langmead; Andrew G W Leslie; Christopher G Tate
Journal:  Nature       Date:  2011-05-18       Impact factor: 49.962

View more
  23 in total

1.  Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.

Authors:  Céline M'Kadmi; Jean-Philippe Leyris; Lauriane Onfroy; Céline Galés; Aude Saulière; Didier Gagne; Marjorie Damian; Sophie Mary; Mathieu Maingot; Séverine Denoyelle; Pascal Verdié; Jean-Alain Fehrentz; Jean Martinez; Jean-Louis Banères; Jacky Marie
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

Review 2.  Minireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling.

Authors:  Cornelia Walther; Stephen S G Ferguson
Journal:  Mol Endocrinol       Date:  2015-05-05

3.  Translating biased signaling in the ghrelin receptor system into differential in vivo functions.

Authors:  Franziska Mende; Cecilie Hundahl; Bianca Plouffe; Louise Julie Skov; Bjørn Sivertsen; Andreas Nygaard Madsen; Michael Lückmann; Thi Ai Diep; Stefan Offermanns; Thomas Michael Frimurer; Michel Bouvier; Birgitte Holst
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-09       Impact factor: 11.205

4.  G Protein and β-arrestin signaling bias at the ghrelin receptor.

Authors:  Tama Evron; Sean M Peterson; Nikhil M Urs; Yushi Bai; Lauren K Rochelle; Marc G Caron; Larry S Barak
Journal:  J Biol Chem       Date:  2014-09-26       Impact factor: 5.157

Review 5.  GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.

Authors:  Ichio Shimada; Takumi Ueda; Yutaka Kofuku; Matthew T Eddy; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2018-11-09       Impact factor: 84.694

6.  Biased agonism and allosteric modulation of G protein-coupled receptor 183 - a 7TM receptor also known as Epstein-Barr virus-induced gene 2.

Authors:  Viktorija Daugvilaite; Christian Medom Madsen; Michael Lückmann; Clara Castello Echeverria; Andreas Walter Sailer; Thomas Michael Frimurer; Mette Marie Rosenkilde; Tau Benned-Jensen
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

7.  Central Ghrelin Resistance Permits the Overconsolidation of Fear Memory.

Authors:  Elia S Harmatz; Lauren Stone; Seh Hong Lim; Graham Lee; Anna McGrath; Barbara Gisabella; Xiaoyu Peng; Eliza Kosoy; Junmei Yao; Elizabeth Liu; Nuno J Machado; Veronica S Weiner; Warren Slocum; Rodrigo A Cunha; Ki A Goosens
Journal:  Biol Psychiatry       Date:  2016-11-29       Impact factor: 13.382

8.  Ghrelin receptor conformational dynamics regulate the transition from a preassembled to an active receptor:Gq complex.

Authors:  Marjorie Damian; Sophie Mary; Mathieu Maingot; Céline M'Kadmi; Didier Gagne; Jean-Philippe Leyris; Séverine Denoyelle; Gérald Gaibelet; Laurent Gavara; Mauricio Garcia de Souza Costa; David Perahia; Eric Trinquet; Bernard Mouillac; Ségolène Galandrin; Céline Galès; Jean-Alain Fehrentz; Nicolas Floquet; Jean Martinez; Jacky Marie; Jean-Louis Banères
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

9.  Differential effects of functionally different histamine H4 receptor ligands on acute irritant dermatitis in mice.

Authors:  Maristella Adami; Cristina Micheloni; Daniela Grandi; Holger Stark
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-25       Impact factor: 3.000

10.  The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

Authors:  Anna Secher; Jacob Jelsing; Arian F Baquero; Jacob Hecksher-Sørensen; Michael A Cowley; Louise S Dalbøge; Gitte Hansen; Kevin L Grove; Charles Pyke; Kirsten Raun; Lauge Schäffer; Mads Tang-Christensen; Saurabh Verma; Brent M Witgen; Niels Vrang; Lotte Bjerre Knudsen
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.